| 2.97 -0.11 (-3.57%) | 12-11 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 4 | 1-year : | 4.67 |
| Resists | First : | 3.43 | Second : | 4 |
| Pivot price | 2.84 |
|||
| Supports | First : | 2.76 | Second : | 2.34 |
| MAs | MA(5) : | 2.92 |
MA(20) : | 2.9  |
| MA(100) : | 3.08 |
MA(250) : | 3.71 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 71 |
D(3) : | 61.2 |
| RSI | RSI(14): 48.9 |
|||
| 52-week | High : | 8.39 | Low : | 2.05 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ZEPP ] has closed below upper band by 34.9%. Bollinger Bands are 3.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3.11 - 3.12 | 3.12 - 3.14 |
| Low: | 2.86 - 2.88 | 2.88 - 2.9 |
| Close: | 2.93 - 2.97 | 2.97 - 3 |
Zepp Health Corporation, together with its subsidiaries, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and smart hearable products, home treadmill, sportswear, home appliances, and smart watch accessories under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.
Wed, 20 Nov 2024
Zepp Health Corporation (NYSE:ZEPP) Q3 2024 Earnings Call Transcript - Insider Monkey
Wed, 20 Nov 2024
Zepp Health Third Quarter 2024 Earnings: US$0.82 loss per share (vs US$0.027 profit in 3Q 2023) - Simply Wall St
Wed, 20 Nov 2024
Zepp Health Corp (ZEPP) Q3 2024 Earnings Call Highlights: Record - GuruFocus.com
Wed, 20 Nov 2024
Zepp Health Corp (ZEPP) Q3 2024 Earnings Call Highlights: Record Gross Margin and Strategic ... - Yahoo Finance
Tue, 19 Nov 2024
Zepp Health Reports Q3 2024 Financial Results - TipRanks
Mon, 18 Nov 2024
Zepp Health Q3 Revenue Falls 49%, But Hits Record 40.6% Gross Margin - StockTitan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Technology
|
|
|
Industry:
Consumer Electronics
|
|
| Shares Out | 7 (M) |
| Shares Float | 106 (M) |
| Held by Insiders | 5.7 (%) |
| Held by Institutions | 43.4 (%) |
| Shares Short | 25 (K) |
| Shares Short P.Month | 15 (K) |
| EPS | -2.45 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 165.6 |
| Profit Margin | -10.5 % |
| Operating Margin | -24.3 % |
| Return on Assets (ttm) | -2.2 % |
| Return on Equity (ttm) | -7.5 % |
| Qtrly Rev. Growth | -54.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 32.49 |
| EBITDA (p.s.) | -2.01 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -1.22 |
| PEG Ratio | 0 |
| Price to Book value | 0.01 |
| Price to Sales | 0.09 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|